课题基金 / 基金详情

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN POST RENAL TRANSPLANTED CHILDREN

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN POST RENAL TRANSPLANTED CHILDREN
肾移植后儿童的重组人类生长激素（NUTROPIN）
批准号：
6297781
负责人：
ROBERT Bruce ETTENGER
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6297781
关键词：
body height child physical development clinical research drug screening /evaluation homologous transplantation human subject kidney transplantation pediatric pharmacology postoperative state recombinant proteins somatotropin transplant rejection

项目摘要

项目成果

ROBERT Bruce ETTENGER的其他基金

相关文献

中文摘要
翻译
本研究的具体目的是：1）确定是否治疗 用Nutropin治疗的生长迟缓的肾移植受者将 生长速度加快，标准化程度提高 身高（SDS）和2）确定儿童肾移植治疗 使用Nutropin的患者将导致以下疾病的发生或进展： 急性同种异体移植物功能障碍或慢性排斥反应， 同种异体移植物功能显著改变。
英文摘要
The specific aims of this study are to 1) determine if treatment of growth retarded renal transplant recipients treated with Nutropin will have acceleration of growth velocity and improvemnet in standardized height (SDS) and 2) determine if treatment of pediatric renal transplant patients with Nutropin will result in the development or progression of acute allograft dysfunction or chronic rejection as measured by a significant change in allograft function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
PHASE I/II OPEN-LABEL PHARMACOKINETIC AND SAFETY STUDY OF ZENAPAX